EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Camouflaged Nanozymes with Oxidation‐Promoting Activities Triggering Ferroptosis for Radio‐Immunotherapy

Kun Qiao, Yongbiao Huang, Shipeng Ning, Meng Lyu, Jieqiong Xie, Shiyuan Zhang, Xiuxin Lu, Yuan Yu, Wei Jiang, Bo Liu, Kelong Fan iD, Tong Liu

Advanced Science · 2025

DOI: 10.1002/advs.202417370 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Kun Qiao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncological Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150000, China. Hauptthemen laut MEDLINE: Ferroptosis, Immunotherapy, Radioimmunotherapy, Breast Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Heilongjiang Province of China: Distinguished Youth Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radioresistance presents a substantial obstacle to achieving optimal therapeutic outcomes for breast cancer treatment. In this study, we develop a cancer cell membrane (CM) ‐ coated nanozyme system (MPPC@CM), specifically designed for radioimmunotherapy to address this issue. This innovative system involves the in situ reduction of platinum and palladium on mesoporous silica nanospheres, followed by functionalization with cinnamaldehyde via surface grafting. The CM coating endows the nanozyme with enhanced tumor‐specific targeting capability due to its homing properties. Upon uptake by tumor cells, MPPC@CM catalytically generates O 2 from H 2 O 2 , mitigating the hypoxic tumor microenvironment and reducing radioresistance. The intracellular glutathione depletion mediated by Michael addition reactions concurrently disrupts endogenous antioxidant defenses against reactive oxygen species (ROS). This redox imbalance is synergistically amplified through nanozyme‐mediated catalytic activities including both peroxidase‐like and oxidase‐like functions. The resultant massive ROS accumulation establishes a self‐reinforcing oxidative cascade that ultimately induces functional inactivation of glutathione peroxidase 4. The immunosuppressive environment is remodeled by this disturbance in redox balance, which accelerates ferroptosis and increases CD8 + T‐cell infiltration and dendritic cell maturation. Overall, this cell membrane‐camouflaged nanozyme holds significant potential to enhance the efficacy of radioimmunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisImmunotherapyRadioimmunotherapyBreast NeoplasmsOxidation-ReductionHumansMiceAnimalsFemaleReactive Oxygen SpeciesCell Line, TumorTumor Microenvironment

Stichwörter der Autor:innen

breast cancerferroptosisnanozymeradioimmunotherapyradioresistance

Substanzen

Reactive Oxygen Species

Autor:innen und Institutionen

  • Department of Oncological Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, 150000, China.
  • Key Laboratory of Tumor Biotherapy of Heilongjiang Province, Harbin Medical University Cancer Hospital, Harbin, 150000, China.
  • Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China.
  • Research Center of Nanomedicine Technology, the Second Affiliated Hospital of Guangxi Medical University, Nanning, 530000, China.
  • Academy of Medical Sciences, Tianjian Laboratory of Advanced Biomedical Sciences, Zhengzhou University, Zhengzhou, Henan, 450000, China.
  • CAS Engineering Laboratory for Nanozyme, Key Laboratory of Biomacromolecules (CAS), CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.

ORCID-Profile: Kelong Fan

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Heilongjiang Province of China: Distinguished Youth Program

Zitieren

APA

Qiao, K., Huang, Y., Ning, S., Lyu, M., Xie, J., Zhang, S., Lu, X., Yu, Y., Jiang, W., Liu, B., Fan, K., & Liu, T. (2025). Camouflaged Nanozymes with Oxidation‐Promoting Activities Triggering Ferroptosis for Radio‐Immunotherapy. Advanced Science. https://doi.org/10.1002/advs.202417370

Vancouver

Qiao K, Huang Y, Ning S, Lyu M, Xie J, Zhang S, et al. Camouflaged Nanozymes with Oxidation‐Promoting Activities Triggering Ferroptosis for Radio‐Immunotherapy. Advanced Science. 2025. doi:10.1002/advs.202417370

BibTeX
@article{Qiao2025,
  author = {Qiao, Kun and Huang, Yongbiao and Ning, Shipeng and Lyu, Meng and Xie, Jieqiong and Zhang, Shiyuan and Lu, Xiuxin and Yu, Yuan and Jiang, Wei and Liu, Bo and Fan, Kelong and Liu, Tong},
  title = {Camouflaged Nanozymes with Oxidation‐Promoting Activities Triggering Ferroptosis for Radio‐Immunotherapy},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202417370}
}
Kostenlos starten →